Cargando…

Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis

Immune checkpoint inhibitors (ICIs) and radiotherapy (RT) combinations for various metastatic cancers are increasingly utilized, yet the augmentation of anti-cancer immunity including distant tumor responses by RT remains ill-characterized. Immunosuppressive tumor microenvironments and defective ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moradi, Luke A., Clark, Curtis A., Schneider, Craig S., Deshane, Alok S., Dobelbower, Michael C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692289/ https://www.ncbi.nlm.nih.gov/pubmed/34956219 http://dx.doi.org/10.3389/fimmu.2021.788499

Ejemplares similares

Pembrolizumab-induced Myasthenia Gravis Relapse after Immunosuppressive Therapy
por: Oshima, Yuki, et al.
Publicado: (2022)

A Case of Pembrolizumab-Induced Myasthenia Gravis
por: Kosick, Thomas I, et al.
Publicado: (2023)

Pembrolizumab‐induced myasthenia gravis with myositis in a patient with lung cancer
por: Hibino, Makoto, et al.
Publicado: (2018)

Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis
por: Ishii, Akiko, et al.
Publicado: (2020)

Pembrolizumab-Induced Myasthenia Gravis and Peripheral Neuropathy: A Case Series
por: McCormack, Sean M, et al.
Publicado: (2023)

Pembrolizumab-Induced Myasthenia Gravis: A Case Report and Review of the Literature
por: Eglenen Polat, Buse, et al.
Publicado: (2023)

Prophylactic Effect of Probiotics on the Development of Experimental Autoimmune Myasthenia Gravis
por: Chae, Chang-Suk, et al.
Publicado: (2012)

Myasthenia Gravis: A Review
por: Jayam Trouth, Annapurni, et al.
Publicado: (2012)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy
por: Onda, Asako, et al.
Publicado: (2019)

Progressive Outer Retinal Necrosis and Immunosuppressive Therapy in Myasthenia Gravis
por: Coisy, Solène, et al.
Publicado: (2014)

Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
por: Stascheit, Frauke, et al.
Publicado: (2022)

Remission of severe myasthenia gravis after autologous stem cell transplantation
por: Schlatter, Monica I., et al.
Publicado: (2023)

Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Todo, Maki, et al.
Publicado: (2019)

Pembrolizumab-Associated Seronegative Myasthenia Gravis in a Patient With Metastatic Renal Cell Carcinoma
por: Pandya, Shaunak K, et al.
Publicado: (2021)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Complete Remission of Generalized Myasthenia Gravis by Corticosteroid Treatment Alone without Thymectomy
por: Kataoka, Hiroshi, et al.
Publicado: (2011)

Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment
por: Cadegiani, Flávio Adsuara
Publicado: (2016)

Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report
por: Tian, Chia-Yi, et al.
Publicado: (2021)

Immunosuppressive and monoclonal antibody treatment for myasthenia gravis: A network meta‐analysis
por: Wang, Liang, et al.
Publicado: (2019)

Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China
por: Ding, Jiaqi, et al.
Publicado: (2020)

Mycobacterium chelonae cutaneous infection: An opportunistic disease in an immunosuppressed patient with myasthenia gravis
por: Granado, Joana, et al.
Publicado: (2020)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Thymectomy in Myasthenia Gravis
por: Dunlop, D. M.
Publicado: (1953)

Thymectomy in Myasthenia Gravis
por: Brown, K. Paterson
Publicado: (1953)

Thymectomy for Myasthenia Gravis
por: Keynes, Geoffrey
Publicado: (1949)

The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021)

Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021)

Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale
por: Barnett, Carolina, et al.
Publicado: (2015)

Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Tomisaki, Ikko
Publicado: (2019)

Value of Adjuvant Radiotherapy for Thymoma with Myasthenia Gravis after Extended Thymectomy
por: Lu, Chang-Feng, et al.
Publicado: (2018)

Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
por: Roh, Hyun Seok, et al.
Publicado: (2011)

Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis
por: Harris, Linda, et al.
Publicado: (2019)

Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report
por: Takai, Manabu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j8ouj9o6v3ut3vv8j1e4sfvs52